Simethicone Does Not Help with Hiccups
Simethicone is not indicated for the treatment of hiccups and should not be used for this purpose. The FDA-approved indication for simethicone is solely for relief of gas and bloating in the gastrointestinal tract 1. There is no evidence—guideline-based, research-based, or otherwise—supporting its use for hiccups.
What Actually Works for Hiccups
Based on systematic reviews of hiccup treatment, the following agents have evidence supporting their use:
First-Line Pharmacologic Options
- Baclofen: Supported by small randomized, placebo-controlled trials and observational data. Less likely to cause side effects during long-term therapy 2, 3
- Gabapentin: Also supported by prospective studies with favorable safety profile for chronic use 2, 3
Second-Line Options
- Metoclopramide: Has randomized controlled trial evidence 2, 3
- Chlorpromazine: The only FDA-approved drug specifically for hiccups, though it carries more side effect risks 2, 3, 4
Reserve Options
Additional agents with case series or observational support include haloperidol, amitriptyline, midazolam, nifedipine, nimodipine, orphenadrine, and valproic acid 2.
Why the Confusion?
The confusion likely stems from simethicone's mention in pediatric emergency medicine guidelines—but only as a side effect notation. One guideline mentions that chlorpromazine (a phenothiazine) can be used to treat "intractable hiccups" 5, but simethicone itself has never been studied or recommended for this indication.
Clinical Approach
For acute hiccups (< 48 hours): Physical maneuvers (stimulating the uvula/pharynx, disrupting respiratory rhythm) are appropriate first-line interventions 4.
For persistent hiccups (> 48 hours) or intractable hiccups (> 1 month):
- Identify and treat underlying cause when possible 3
- Consider empirical trial of anti-reflux therapy 3
- If no treatable cause identified, initiate baclofen or gabapentin as first-line pharmacotherapy 2, 3
- Reserve metoclopramide or chlorpromazine for refractory cases 3
Important caveat: No high-quality randomized controlled trials exist for hiccup treatment. Therapy selection should account for the patient's comorbidities, potential drug interactions, and the side effect profiles of available agents 2.